Google DeepMind Releases AlphaGenome 2 Model
Google DeepMind launches AlphaGenome 2, a conditional DNA sequence model predicting regulatory activity and variant effects by cell type.
Stock photo for illustration only, not from the actual event
- Google DeepMind releases AlphaGenome 2 DNA sequence model
- Predicts regulatory activity and variant effects per cell type
- Available via AlphaGenome API for non-commercial research
Google DeepMind has officially released AlphaGenome 2, a conditional DNA sequence model designed to predict regulatory activity and genetic variant effects tailored to specific cell types.
This innovative model aims to help researchers better comprehend cellular-level genetic mechanisms by analyzing how variations in DNA sequences impact distinct cell categories with high precision.
Stock photo for illustration only, not from the actual event
The development of advanced artificial intelligence models for predicting genetic impacts is a significant milestone in computational biology and precision medicine. It helps researchers simulate mutation effects across different cell types beforehand, potentially reducing laboratory experimental time and costs.
Researchers interested in utilizing the tool can access AlphaGenome 2 through the AlphaGenome API, which is currently made available specifically for non-commercial research purposes.
Source: MarkTechPost
Found something wrong in this article? Report an issue with this article
Comments
Leave a Comment